Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Healthcare Triangle, Inc.HCTI · Entity 7909 | Director · Head of M&A | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Healthcare Triangle, Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,129 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Other · Acquired 34,129 · Balance 54,129 F1: Represents restricted shares of common stock of Healthcare Triangle, Inc. (the "Issuer") distributed by SecureKloud Technologies, Inc., parent entity of the Issuer, to its shareholders, vide the share exchange transaction that was completed on March 31, 2025 pursuant to the Share Exchange Agreement, dated as of March 31, 2025, by and among the SecureKloud Technologies, Inc., and the shareholders of SecureKloud Technologies, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of common stock of Healthcare Triangle, Inc. (the "Issuer") distributed by SecureKloud Technologies, Inc., parent entity of the Issuer, to its shareholders, vide the share exchange transaction that was completed on March 31, 2025 pursuant to the Share Exchange Agreement, dated as of March 31, 2025, by and among the SecureKloud Technologies, Inc., and the shareholders of SecureKloud Technologies, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2025 Filed Apr 2, 2025 21:12 UTC | Healthcare Triangle, Inc. HCTI · Entity 7909 | OtherCommon Stock | 34,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028137 · ownership.xml · nonDerivative · entry 1 Kizhakevilayil Shibu · CIK 0001889540 · Director · Head of M&A 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,129 F1 · kind: Represents restricted shares of common stock of Healthcare Triangle, Inc. (the "Issuer") distributed by SecureKloud Technologies, Inc., parent entity of the Issuer, to its shareholders, vide the share exchange transaction that was completed on March 31, 2025 pursuant to the Share Exchange Agreement, dated as of March 31, 2025, by and among the SecureKloud Technologies, Inc., and the shareholders of SecureKloud Technologies, Inc. Read SEC document |
| April 27, 2020 Filed Mar 21, 2023 13:17 UTC | Healthcare Triangle, Inc. HCTI · Entity 7909 | Disposition to issuerCommon Stock | 200,000 | $0.00 | $200.00 |
DisclosureSEC source: 0001607062-23-000139 · primary_doc.xml · nonDerivative · entry 1 Kizhakevilayil Shibu · CIK 0001889540 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · ownership.direct: These shares were inadvertently omitted from the reporting person's original Form 3, and the subsequent Form 5 filed by the reporting person after the original Form 3 was filed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.